Protein Expression Market 2023 Key Players Merck Group, Agilent Technologies, Promega Corporation, Bio-Rad Laboratories, New England Biolabs

The protein expression market predicts that the market will have a healthy growth for the next few years. According to the report, the size of the protein expression market is projected to reach $3.0 billion by 2023. Increasing prevalence of chronic diseases, aging population, increase in growth in life science sector, availability of funding for protein-based research and technological advancements are key drivers for the growth of market.

Explore report sample at: http://bit.ly/2FDEb7d

The global protein expression market is highly consolidated as the top three companies constitute for two-thirds of the overall market share in 2016. ThermoFisher Scientific Inc., Merck KGaA and Agilent Technologies led the global market in 2016. ThermoFisher Scientific Inc. held almost one-third of the global protein expression market share in 2016, primarily due to the availability of protein expression products as prokaryotic, mammalian, insect cell, yeast, cell free and algae-based systems. Merck KGaA was the second largest player in global protein expression market in 2016. There is stiff competition among Promega Corporation, New England Biolabs Inc. and Takara Bio. Inc. in the global market as only these companies market cell-free based protein expression systems. Other major players in the market are Qiagen N.V., Lonza Group Ltd., Genscript Biotech Corporation, New England Biolabs Inc. and Bio-Rad Laboratories, Inc.

Browse report at: http://bit.ly/2Kp81LV

Recombinant production of proteins is one of the most powerful molecular biology techniques used in the life sciences sector for its industrial application in producing biopharmaceuticals. The ability of producing abundant volume of purified and desired recombinant protein leads to its extensive potential application such as, in industrial processes, or its use to diagnose or treat diseases. Increase in research to understand efficient expression of novel and difficult proteins through protein and cell line engineering is an essential step to support future drug discoveries. A major prerequisite for drug discovery is that recombinant proteins can be produced in adequate amount and are of appropriate quality. Major players are focusing on expanding their research activities and investing on recombinant based protein expression for production of large volume of recombinant protein to be used as biotherapeutics and are also to support drug discoveries.

Pre-Purchase Inquiry at: http://bit.ly/2AacTzC

Geographically, the Asia-Pacific protein expression market has been experiencing growth due increasing prevalence of diseases such as anaphylaxis and diabetes, increasing aging population, increased R&D spending, and increasing per capita income. According to International Diabetes Federation, China, India, Brazil, Bangladesh and Indonesia are the top five countries with high number of diabetic patients and have emerged as a potential market for protein expression.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347 5th Ave. #1402- 210
New York City, NY 10016 United States
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.